A prospective randomized trial of two popular mononuclear cell collection sets for autologous peripheral blood stem cell collection in multiple myeloma

Transfusion

Volumn 50, Issue 1, 2010, Pages 100-119

  Cooling, Laura ^a   Hoffmann, Sandra ^a   Herrst, Michelle ^a   Muck, Charles ^a   Armelagos, Heidi ^a   Davenport, Robertson ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; THALIDOMIDE;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD TRANSFUSION REACTION; CANCER CHEMOTHERAPY; CARDIOVASCULAR DISEASE; CD34 SELECTION; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; FEMALE; FEVER; HUMAN; INCIDENCE; LEUKAPHERESIS; LEUKOCYTE; LUNG DISEASE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MULTIPLE MYELOMA; MUSCLE CRAMP; NAUSEA AND VOMITING; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RIGOR; STATISTICS;

ANTIGENS, CD34; COMBINED MODALITY THERAPY; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOGLOBULIN G; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; PLATELET COUNT; PROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 73649147383     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02350.x     Document Type: Article

References (67)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006 354 : 1813 26.
2. Attal M, Moreau P, Avet-Loiseau H, Harousseau JL. Stem cell transplantation in multiple myeloma. Hematology 2007 311 6.
3. Koreth J, Cutler CS, Djulbegovic B, Behl R, Schlossman RL, Munshi NC, Richardson PG, Anderson KC, Soiffer RJ, Alyea EP. High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. Biol Blood Marrow Transplant 2007 13 : 183 96.
4. Mehta J, Tricot G, Jagannath S, Ayers D, Singhal S, Siegel D, Desikan K, Nunshi N, Fassas A, Mattox S, Vesole D, Crowley J, Barlogie B. Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft. Bone Marrow Transplant 1998 21 : 887 92.
5. Qazilbash MH, Saliba R, De Lima M, Hosing C, Couriel D, Aleman A, Roden L, Champlin R, Giralt SA. Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma. Cancer 2006 106 : 1084 9.
6. Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG, Monconduit M, Hulin C, Caillot D, Bouabdallah R, Voillat L, Sotto JJ, Grosbois B, Bataille R. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 2003 349 : 2495 502.
7. Cavo M, Tosi P, Zamagni E, Cellini C, Tacchetti P, Patriarca F, Di Raimondo F, Volpe E, Ronconi S, Cangini D, Narni F, Carubelli A, Masini L, Catalano L, Fiacchini M, de Vivo A, Gozzetti A, Lazzaro A, Tura S, Baccarani M. Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study. J Clin Oncol 2007 25 : 2434 41.
8. Morris C, Iacobelli S, Brand R, Bjorkstrand B, Drake M, Niederwieser D, Gahrton G. Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European group for blood and marrow transplantation registry study. J Clin Oncol 2004 22 : 1674 81.
9. Bruno B, Rotta M, Patriarca F, Mordini N, Allione B, Carnevale-Schianca F, Giaccone L, Sorasio R, Omede P, Baldi H, Bringhen S, Massaia M, Aglietta M, Levis A, Gallamini A, Fanin R, Palumbo A, Storb R, Ciccone G, Boccadoro M. A comparison of allografting with autografting for newly diagnosed myeloma. N Eng J Med 2007 356 : 1110 20. (Pubitemid 46425595)
10. Attal M, Harousseau JL, Leyvraz S, Doyen C, Hulin C, Benboubker L, Agha IY, Bourhis JH, Garderet L, Pegourie B, Dumontet C, Renaud M, Voillat L, Berthou C, Marit G, Monconduit M, Caillot D, Grobois B, Avet-Loiseau H, Moreau P, Facon T. Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. Blood 2006 108 : 3289 94.
11. Abdelkefi A, Ladeb S, Torjman L, Ben Othman T, Lakhal A, Ben Romdhane N, El Omri H, Elloumi M, Belaaj H, Jeddi R, Aissaoui L, Ksouri H, Ben Hassen A, Msadek F, Saad A, Hsairi M, Boukef K, Amouri A, Louzir H, Dellagi K, Ben Abdeladhim A. Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial. Blood 2008 111 : 1805 10.
12. Stadtmauer EA. Multiple myeloma, 2004 - one or two transplants? N Eng J Med 2003 349 : 2551 3.
13. Fruehauf S, Klaus J, Huesing J, Veldwijk MR, Buss EC, Topaly J, Seeger T, Zeller LW, Moehler T, Ho AD, Goldschmidt H. Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Bone Marrow Transplant 2007 39 : 743 50.
14. Badros A, Goloubeva O, Fenton R, Rapoport AP, Akpek G, Harris C, Ruehle K, Westphal S, Meisenberg B. Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma. Clin Lymphoma Myeloma 2006 7 : 21 6.
15. Jacoub JF, Suryadevara U, Pereyra V, Colon D, Fontelonga A, MacKintosh FR, Hall SW, Ascensao JL. Mobilization strategies for the collection of peripheral blood progenitor cells: results from a pilot of delayed addition G-CSF following chemotherapy and review of the literature. Exp Hematol 2006 34 : 1443 50.
16. Koenigsmann M, Jentsch-Ullrich K, Mohren M, Becker E, Heim M, Franke A. The role of diagnosis in patients failing peripheral blood progenitor cell mobilization. Transfusion 2004 44 : 777 84.
17. Morris CL, Siegel E, Barlogie B, Cottler-Fox M, Lin P, Fassas A, Zangari M, Anaissie E, Tricot G. Mobilization of CD34+ cells in elderly patients (>70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen. Br J Haematol 2003 120 : 413 23.
18. de al Rubia J, Blade J, Lahuerta JJ, Ribera JM, Martinez R, Alegre A, Garcia-Larana J, Fernandez P, Sureda A, de Arriba F, Carrera D, Besalduch J, Boyera RG, Bernal LP, Hernandez MT, Garcia PR, Perez-Calvo J, Alcala A, Casado LF, Miguel JS. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study. Haematologica 2006 92 : 621 7.
19. Alegre A, Tomas JF, Marinez-Chamorro C, Gil-Fernandez JJ, Fernandez-Villalta MJ, Arranz R, Diaz MA, Granda A, Bernardo MR, Escudero A, Lopez-Lorenzo JL, Fernandez-Ranada JM. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-GSF alone. Bone Marrow Transplant 1997 20 : 211 7.
20. Hiwase DK, Bollard G, Hiwase S, Bailey M, Muirhead J, Schwarer AP. Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma. Cytotherapy 2007 9 : 539 47.
21. Kroger N, Renges H, Kruger W, Gutensohn K, Loliger C, Carrero I, Cortes L, Zander AR. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation. Br J Haematol 2000 111 : 761 5.
22. Gojo I, Guo C, Sarkodee-Adoo C, Meisenberg B, Fassas A, Rapoport AP, Cottler-Fox M, Heyman M, Takebe N, Tricot G. High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity. Bone Marrow Transplant 2004 34 : 69 76.
23. Zubair AC, Grant R, Wu W, Tun H, Rivera C, Moreno-Aspitia A, Joyce M, Roy V, Colon-Otero G, Solberg LA. Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients. Transfusion 2008 48 : 1106 14.
24. Yu J, Leisenring W, Bensinger WI, Holmberg LA, Rowley SD. The predictive value of white cell of CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield. Transfusion 1999 39 : 442 50.
25. Ford CD, Chan KJ, Reilly WF, Petersen FB. An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors. Transfusion 2003 43 : 622 5.
26. Benjamin RJ, Linsley L, Fountain D, Churchill WH, Sieff C, Cannon ME, Uhl L, Gaynes L, Antin JH, Wheeler C. Preapheresis peripheral blood CD34+ mononuclear cell counts as predicators of progenitor cell yield. Transfusion 1997 37 : 79 85.
27. Moog R. Management strategies for poor peripheral blood stem cell mobilization. Transfus Apher Sci 2008 38 : 229 36.
28. Dolan K, Blume C, Capone C, Cooling L, Champney D, Henry JB, Huebner P, Sisson S. Anatomic placement affects the performance of the Neostar Pheres-Flow Catheter [abstract]. J Clin Apher 2000 15 : A69.
29. Lin JS, Burgstaler EA, Pineda AA, Gertz MA. Effects of whole blood flow rates on mononuclear cell yields during peripheral blood stem cell collection using Fenwal CS3000 Plus. J Clin Apher 1995 10 : 7 11.
30. Burgstaler JE, Pineda AA, Winter JL. Effects of high whole blood flow rates and high peripheral WBC on CD34+ yield and cross-cellular contamination [abstract]. Cytotherapy 2003 5 : 446.
31. Ford CD, Pace N, Lehman C. Factors affecting the efficiency of collection of CD34-positive peripheral blood cells by a blood cell separator. Transfusion 1998 38 : 1046 50.
32. Bellavita P, Celega E, Poma R. Comparison of performance of six different cell separators in collecting peripheral blood mononuclear cells. Transfus Sci 1997 18 : 215 21.
33. Dzieczkowski JS, McGonigal M, Cook J, Sugrue M, Andersen J, Anderson KC. A comparison of peripheral blood stem cell apheresis using the Fenwal CS3000 Plus and COBE Spectra. Transfus Sci 1995 16 : 71 7.
34. Berretta F, van den Bosch S, Castelli D, Cavalli F, Ghielmini M. Intrapatient comparison of an intermittent and a continuous flow cell separator for the collection of progenitor and stem cells from the blood. Vox Sang 1998 75 : 149 53.
35. Ikeda K, Ohto H, Nemoto K, Yamamoto G, Kato K, Ogata T, Shichishima T, Maruyama Y. Collection of MNCs and progenitor cells by two separators for transplantation: a randomized crossover trial. Transfusion 2003 43 : 814 9.
36. Mehta J, Powles R, Treleaven J, Millar B, Proctor H, Cabral S, Shephard V, Singhal S. Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS-3P cell separators for leukapheresis after high-dose filgrastim in patients with hematologic malignancies. J Clin Apher 1997 12 : 63 7.
37. Morton JA, Baker DP, Hutchins CJ, Durran ST. The COBE Spectra cell separator is more effective than the Haemonetics MCS-3P cell separator for peripheral blood progenitor cell harvest after mobilization with cyclophosphamide and filgrastim. Transfusion 1997 37 : 631 3.
38. Heuft HG, Dubiel M, Rick O, Kingreen D, Serke S, Schwella N. Inverse relationship between patient peripheral blood CD34+ cell counts and collection efficiency for CD34 cells in two automated systems. Transfusion 2001 41 : 1008 13.
39. Wilke R, Brettell M, Prince HM, Wolf M, McKenna R, Serpell E, Molloy M, Stevens H, Quinn M, Gates P, Chapple P. Comparison of COBE® Spectra™ software version 4.7 PBSC and version 6.0 PBSC™ program. J Clin Apher 1999 14 : 26 30.
40. Schreiner T, Wiesneth M, Krug E, Kalinova J, Buchele H, Maccari B, Erne E, Bischof C, De Reys S. Collection of allogeneic peripheral blood progenitor cells by two protocols on an apheresis system. Transfusion 1998 38 : 1051 5. (Pubitemid 28549007)
41. Ravagnani F, Siena S, De Reys S, Di Nicola M, Notti P, Giardini R, Bregni M, Matteucci P, Gianni AM, Pellegris G. Improved collection of mobilized CD34+ hematopoietic progenitor cells by a novel automated system. Transfusion 1999 39 : 48 55.
42. Rowley SD, Prather K, Bui KT, Appel M, Felt T, Bensinger WI. Collection of peripheral blood progenitor cells with an automated leukapheresis system. Transfusion 1999 39 : 1200 6.
43. Green RH, Watson D, Buchanan S, Morrison AE. A prospective randomized concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (AutoPBSC™) and Haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non-haematological malignancies. Transfus Sci 2001 24 : 85 90.
44. Adorno G, Del Proposto G, Palombi F, Bruno A, Ballatore G, Postorino M, Tendas A, Del Poeta G, Isacchi G, Amadori S. Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators. Transfus Apher Sci 2004 30 : 131 6.
45. Lee CK, Barlogie B, Munshi N, Zangari M, Fassas A, Jacobson J, van Rhee F, Cottler-Fox M, Muwalla F, Tricot G. DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma. J Clin Oncol 2003 21 : 2732 9.
46. Shah-Khan F, Cooling L, Hoffmann S, Mineishi S, Herrst M, Davenport R. DT-PACE is equivalent or superior to cytoxan+G-CSF or G-CSF alone for the collection of CD34 cells in multiple myeloma [abstract]. Transfusion 2008 48 Suppl : 126A.
47. Hoffmann S, Zhou L, Gu Y, Davenport R, Cooling L. Delayed platelet engraftment in group O patients after autologous progenitor cell transplantation. Transfusion 2005 45 : 885 95.
48. Bolan CD, Cecco SA, Wesley RA, Horne M, Yau YY, Remaley AT, Childs RW, Barrett AJ, Rehak NN, Leitman SF. Controlled study of citrate effects and response to IV calcium administration during allogeneic peripheral blood progenitor cell donation. Transfusion 2002 42 : 935 46.
49. Sutherland DR, Anderson L, Keeney M, Nayar M, Chin-Yee R. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society for Hematotherapy and Graft Engineering. J Hematother 1996 5 : 213 26.
50. Lacey M. Summaries of topics: inference in linear regression. Yale University Department of Statistics, Introduction to Statistics 101-103, 1997-98. [cited 2009 June]. Available from: http://www.stat.yale.edu/Courses/ 1997-98/101/linregin.htm
51. Gidron A, Verma A, Doyle M, Boggio L, Evens A, Gordon L, Singhal S, Tallman M, Williams S, Winter J, Mehta J. Can the stem cell mobilization technique influence CD34+ cell collection efficiency of procedures in patients with hematologic malignancies Bone Marrow Transplant 2005 35 : 243 6.
52. Leblond PF. Hemorheology and blood diseases. In : Chien S, Dormandy J, Ernst E, Matrai A, editors. Clinical hemorheology. Dordrecht (The Netherlands) : Marinuse Nijhoff Publishers 1987. p. 227 49.
53. Micallef IN, Apostolidis J, Rohatiner AZ, Wiggins C, Crawley CR, Foran JM, Leonhardt M, Bradburn M, Okukenu E, Salam A, Matthews J, Cavenagh JD, Gupta RK, Lister TA. Factors which predict unsuccessful mobilization of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma. Hematol J 2000 1 : 367 73.
54. Kuittinen T, Nousiainen T, Halonen P, Mahlamaki E, Jantunen E. Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 2004 33 : 907 12.
55. Hill L, Ratliff B, Richman C, Fernando LP. Comparison of two methods for peripheral blood stem cell collection in adult patients using the COBE Spectra™. J Clin Apher 2008 23 : A43.
56. Perseghin P, Dassi M, Balduzzi A, Rovelli A, Bonanomi S, Uderzo C. Mononuclear cell collection in patients undergoing extra-corporeal photo-chemotherapy for acute and chronic graft-vs.-host disease (GvHD): comparison between COBE Spectra Version 4.7 and 6.0 (AutoPBSC). J Clin Apher 2002 17 : 65 71
57. Cooling L, Gorlin JB. Transfusion reactions associated with hematopoietic progenitor cell reinfusion. In : Popovsky MA, editor. Transfusion reactions. 3rd ed. Bethseda : AABB Press 2007. p. 302 22.
58. Zambelli A, Poggi G, da Prada GA, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P, Robustelli della Cuna G. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Cancer Res 1998 18 : 4705 8.
59. Calmels B, Lemarie C, Esterni B, Malugani C, Charbonnier A, Coso D, Shiaono de Colella JM, Deconinck E, Caillot D, Viret F, Ladaique P, Lapierre V, Chabannon C. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion 2007 47 : 1268 75.
60. Richa E, Bryant S, Greiner C, Gastineau D. Correlation between the amount of infused granulocytes and side effects of stem cells infusion [abstract]. Transfusion 2008 48 Suppl : 126A.
61. Mahe B, Milpied N, Hermouet S, Robillard N, Moreau P, Letortorec S, Rapp MJ, Bataille R, Harousseau JL. G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma. Br J Haematol 1996 92 : 263 8.
62. Kroger N, Zeller W, Fehse N, Hassan HT, Kruger W, Gutensohn K, Lolliger C, Zander AR. Mobilizing peripheral blood stem cells with high dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients. Br J Haematol 1998 102 : 1101 6.
63. D'Hondi L, Emmons RV, Andre M, Guillaume T, Feyens AM, Canon JL, Humblet Y, Longueville J, Symann M. The administration of 10 μg/kg granulocyte-colony-stimulating factor (G-CSF) alone results in a successful peripheral blood stem cell collection when previous mobilization with chemotherapy and hematopoietic growth factor failed. Leuk Lymphoma 1999 34 : 105 9.
64. Kuroiwa M, Okamura T, Kanaji T, Okamura S, Harada M, Niho Y. Effects of granulocyte colony-stimulating factor on the hemostatic system in healthy volunteers. Int J Hematol 1996 63 : 311 6.
65. Nomura S, Inami N, Kanazawa S, Iwasaka T, Fukuhara S. Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF. Stem Cells 2004 22 : 696 703.
66. Topcuoglu P, Arat M, Dalva K, Ozcan M. Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors. Bone Marrow Transplant 2004 33 : 171 6.
67. Burgstaler EA, Mako A, Winters JL. Use of manual color monitoring to enhance hematopoietic progenitor cell collection on Fenwal Amicus [abstract]. J Clin Apher 2008 23 : A44.